The effect of a diphosphonate on uremic hyperparathyroidism.
D000818:Animals; D001862:Bone Resorption / Q000209:etiology; D001842:Bone and Bones / Q000378:metabolism; D002118:Calcium / Q000097:blood; D002247:Carbon Isotopes; D003404:Creatinine / Q000097:blood; D005269:Femur / Q000378:metabolism; D006962:Hyperparathyroidism, Secondary / Q000188:drug therapy* / Q000209:etiology; D007676:Kidney Failure, Chronic / Q000150:complications*; D008159:Lumbar Vertebrae / Q000378:metabolism; D009929:Organ Size; D063065:Organophosphonates / Q000097:blood / Q000627:therapeutic use* / Q000652:urine; D010280:Parathyroid Glands; D010758:Phosphorus / Q000097:blood; D051381:Rats; D014511:Uremia / Q000150:complications
D002247:Carbon Isotopes; D063065:Organophosphonates; D010758:Phosphorus; D003404:Creatinine; D002118:Calcium